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Pathogenic Inflammation in Fungal Infections:
the Contribution of the Th17 Pathway
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Perugia, 06126 Perugia, Italy
Background: The inflammatory response to fungi may serve to
limit infection but an overzealous or heightened inflammatory re-
sponse may contribute to pathogenicity, as documented by the
occurrence of intractable fungal infections in patients with im-
munoreconstitution disease or primary immunodeficiencies asso-
ciated with heightened immune reactivity. IL-12, by initiating and
maintaining Th1 responses, was thought to be responsible for over-
reacting immune and autoimmune disorders. The newly described
Th17 pathway is now thought to contribute to immune pathogene-
sis previously attributed to the Th1 lineage.
Objective: This study examined the role of Th17 in inflammation
and immunity to Candida albicans or Aspergillus fumigatus in ex-
perimental models of infections.
Methods: Mice with selected genetic deficiencies (i.e, IL-23, IL-12
or both or TLR-deficient) were exposed to C. albicans or A. fu-
migatus and assessed for susceptibility to infection, gut or airway
inflammation, and parameters of innate and adaptive immunity.
Results: The Th17 pathway – and not the uncontrolled Th1 re-
sponse – was associated with defective pathogen clearance, failure
to resolve inflammation and initiate protective immune responses.
Conditions of high-threat inflammation predisposed to Th17 acti-
vation, whereby the unrestricted fungal growth resulted from the
activation of not only pathogenic Th17 cells but also Th2 cells,
whose activation is strictly dependent on fungal burden. Block-
ade of IL-17/IL-23 prevented pathogenic inflammatory responses,
ameliorated infections and restored protective Th1 antifungal re-
sistance, thus causally linking pathogenic inflammation to Th17 de-
velopment.
Conclusion and clinical implications: The above findings provide a
molecular connection between the failure to resolve inflammation
and lack of antifungal immune resistance and point to strategies
for immune therapy of fungal infections that attempt to limit in-
flammation to stimulate an effective immune response. Inhibition
of the Th17 pathway may potentially represent a novel strategy
for the prevention of inflammatory immunity and allergy in fungal
diseases.
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Aspergillus Attenuates Distinct Host TLR2 & TLR4
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Background: Aspergillus fumigatus is the most commonly identi-
fied cause of invasive aspergillosis in immunocompromised hosts
with significant attributable mortality and morbidity. To date, not
much is known about the pathophysiology and host response to
such mould infections
Objective: We aimed to study how A. fumigatus may modulate the
host innate immune system to its own advantage in the course of
invasive disease.
Methods: Peripheral blood mononuclear cells (PBMCs), isolated
from venous blood of healthy volunteers by density centrifugation
on Ficoll-Hypaque, were preincubated with A. fumigatus conidia
(107cfu/ml) as a priming stimulus in RPMI for 24h, after which
cells were exposed to a secondary stimulus to detect the respec-
tive immunomodulatory effects. As secondary stimulus, TLR2 lig-
and Pam3Cys 10ug/ml or TLR4 ligand E. coli lipopolysaccharide
1ng/ml was used. Cytokine production (IL-6, TNF, IL-1b) was mea-
sured by ELISA. Quantitative PCR was performed for TLR2, TLR4
mRNA (24h after priming of PBMCs with Aspergillus); IL-1b and TNF
mRNA (4h after secondary stimuli). Mean relative mRNA expression
was measured. To analyse the involvement of phagocytic activity
and dectin-1 receptor, cytochalasin B and laminarin were added re-
spectively. Results were pooled from at least 3 sets of experiments.
Statistical significance was set at 0.05 (Wilcoxon Signed Rank).
Results: PBMCs primed with A. fumigatus conidia produced signifi-
cantly less IL-6 and IL-1b in response to subsequent TLR2 and TLR4
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